VAS2B062

LNCaP-Cas9

This LNCaP Cas9 stable cell line is made by lentivirus. Cas9 is stably expressed, and the Cas9 activity is validated by gene editing experiments.Please feel free to contact us for more cell information and order placing.

Images

Key facts

Product name
LNCaP-Cas9
Catalog No.
VAS2B062
Form
Ship in dry ice
Note
FOR RESEARCH USE ONLY
Product size: 1*10^6 cells/vial
Product price: Please inquire
Lead time: 1 week

This LNCaP Cas9 stable cell line is made by lentivirus. Cas9 is stably expressed, and the Cas9 activity is validated by gene editing experiments.Please feel free to contact us for more cell information and order placing.

Key facts
Product name
LNCaP-Cas9
Catalog No.
VAS2B062
Shipping and Storage
Ship in dry ice, store in liquid nitrogen vapor phase
Properties
Host cell line
Human prostate cancer cell line (Lncap)
Target
Cas9 Nuclease
Application
CRISPR/Cas9 gene editing
Method
Lentivirus tranduction
Form
Poly-clonal
Quality control
Gene editing test
STR profiling
Cell culture
Biosafety level
2
Adherent/suspension
Adherent
Morphology
Epithelial-like
Culture medium
RPMI-1640+10% FBS
Freezing medium
50% RPMI-1640+40% FBS+10% DMSO

Downloads

Datasheet

Safety datasheet

Protocol

For further support, please contact us.

*Publications utilizing this product should include the following acknowledgment: "The LNCaP-Cas9 (Cat. No. VAS2B062) was obtained from Vitro Biotech, Inc."

discount picture
×
logo

You've Unlocked

$100 OFF

Your First Order: